Pfizer investing US$26 million in Mexico during 2018

Neither the presidential elections, nor the renegotiation of the North American Free Trade Agreement (NAFTA) or the commercial changes in the world, are going to stop investment from the US company Pfizer in Mexico, with plans to exert US$26 million in 2018. This amount includes US$8 million to continue the modernization of its Toluca plant, and the rest will be used to continue investing in clinical research and social responsibility programs. The company ended the year 2017 with growth rates of 9%, while the pharmaceutical market had growth records of 5%.